HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Maciej Zabel Selected Research

Topotecan (Hycamtin)

4/2021Piperine Targets Different Drug Resistance Mechanisms in Human Ovarian Cancer Cell Lines Leading to Increased Sensitivity to Cytotoxic Drugs.
4/2019PTPRK Expression Is Downregulated in Drug Resistant Ovarian Cancer Cell Lines, and Especially in ALDH1A1 Positive CSCs-Like Populations.
10/2017New and Old Genes Associated with Primary and Established Responses to Cisplatin and Topotecan Treatment in Ovarian Cancer Cell Lines.
9/2017The significance of lumican expression in ovarian cancer drug-resistant cell lines.
7/2017Microarray-based detection and expression analysis of new genes associated with drug resistance in ovarian cancer cell lines.
1/2017New and Old Genes Associated with Topotecan Resistance Development in Ovarian Cancer Cell Lines.
10/2016Analysis of MDR genes expression and cross-resistance in eight drug resistant ovarian cancer cell lines.
1/2016Increased Expression of Several Collagen Genes is Associated with Drug Resistance in Ovarian Cancer Cell Lines.
8/2015Inhibition of protein glycosylation reverses the MDR phenotype of cancer cell lines.
11/2014Microarray-based detection and expression analysis of extracellular matrix proteins in drug‑resistant ovarian cancer cell lines.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Maciej Zabel Research Topics

Disease

67Neoplasms (Cancer)
06/2022 - 01/2003
37Ovarian Neoplasms (Ovarian Cancer)
06/2022 - 11/2003
18Breast Neoplasms (Breast Cancer)
12/2016 - 01/2004
18Carcinoma (Carcinomatosis)
12/2012 - 01/2003
6Infections
06/2022 - 01/2002
6Chronic Hepatitis C
01/2009 - 01/2004
5Neoplasm Metastasis (Metastasis)
12/2016 - 03/2003
5Lymphoma (Lymphomas)
12/2009 - 01/2004
4Circulating Neoplastic Cells
09/2021 - 10/2012
4Lung Neoplasms (Lung Cancer)
05/2007 - 01/2003
3Prostatic Neoplasms (Prostate Cancer)
09/2021 - 01/2018
3Necrosis
12/2015 - 01/2002
3Colorectal Neoplasms (Colorectal Cancer)
08/2015 - 12/2008
3B-Cell Lymphoma (Lymphoma, B Cell)
08/2010 - 11/2003
3Hepatitis C
01/2009 - 01/2007
2Melanoma (Melanoma, Malignant)
09/2021 - 09/2009
2Colonic Neoplasms (Colon Cancer)
06/2017 - 01/2014
2Thyroid Neoplasms (Thyroid Cancer)
04/2017 - 02/2004
2Lymphatic Metastasis
12/2016 - 11/2015
2Ductal Carcinoma
01/2016 - 12/2012
2Adenocarcinoma
11/2015 - 02/2004
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2014 - 09/2008
2Crohn Disease (Crohn's Disease)
10/2013 - 01/2013
2Nephrotic Syndrome (Syndrome, Nephrotic)
01/2013 - 01/2011
2Cholelithiasis
12/2011 - 12/2010
2Endometrial Neoplasms (Endometrial Cancer)
04/2011 - 12/2008
2Pancreatic Neoplasms (Pancreatic Cancer)
02/2010 - 01/2010
2Laryngeal Neoplasms (Laryngeal Cancer)
05/2007 - 01/2007
2Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2006 - 01/2004
2Carcinoid Tumor (Carcinoid)
11/2003 - 01/2003
2Experimental Liver Neoplasms
07/2003 - 01/2002
1Coronary Artery Disease (Coronary Atherosclerosis)
10/2019
1Developmental Defects of Enamel
01/2018

Drug/Important Bio-Agent (IBA)

37Proteins (Proteins, Gene)FDA Link
06/2022 - 11/2003
20Pharmaceutical PreparationsIBA
06/2022 - 03/2007
20Cisplatin (Platino)FDA LinkGeneric
04/2019 - 11/2003
17Paclitaxel (Taxol)FDA LinkGeneric
06/2022 - 11/2003
15Doxorubicin (Adriamycin)FDA LinkGeneric
06/2022 - 07/2003
14Topotecan (Hycamtin)FDA LinkGeneric
04/2021 - 07/2012
12MetallothioneinIBA
02/2016 - 11/2003
12ParaffinIBA
01/2008 - 03/2003
11Messenger RNA (mRNA)IBA
06/2022 - 01/2013
7Vincristine (Oncovin)FDA LinkGeneric
04/2019 - 01/2013
7MelatoninIBA
06/2017 - 01/2002
7Member 1 Subfamily B ATP Binding Cassette TransporterIBA
05/2016 - 01/2005
6Estrogen ReceptorsIBA
01/2016 - 01/2009
6Cyclooxygenase 2 (Cyclooxygenase-2)IBA
05/2014 - 01/2005
6AntibodiesIBA
01/2013 - 03/2003
5Biomarkers (Surrogate Marker)IBA
09/2021 - 09/2010
5Methotrexate (Mexate)FDA LinkGeneric
04/2019 - 01/2013
5Cytostatic AgentsIBA
07/2017 - 01/2002
5PlatinumIBA
08/2014 - 03/2007
5CytokinesIBA
01/2006 - 01/2003
4Proliferating Cell Nuclear Antigen (PCNA)IBA
04/2017 - 11/2003
4AntigensIBA
02/2016 - 01/2005
4Ki-67 Antigen (Ki 67 Antigen)IBA
09/2014 - 01/2007
4QuercetinIBA
09/2012 - 02/2004
4Hormones (Hormone)IBA
09/2011 - 01/2003
4Interleukin-2 (IL2)IBA
08/2010 - 01/2003
4Progesterone Receptors (Progesterone Receptor)IBA
01/2010 - 01/2004
4Monoclonal AntibodiesIBA
11/2006 - 01/2005
3Antineoplastic Agents (Antineoplastics)IBA
09/2021 - 05/2007
3SurvivinIBA
04/2017 - 09/2010
3Caspase 3 (Caspase-3)IBA
12/2015 - 01/2008
3Glycoproteins (Glycoprotein)IBA
08/2015 - 12/2010
3Protein Isoforms (Isoforms)IBA
08/2014 - 12/2012
3Epithelial Cell Adhesion MoleculeIBA
01/2014 - 01/2012
3ATP-Binding Cassette Transporters (ABC Transporters)IBA
09/2013 - 09/2008
3Estrogen Receptor alphaIBA
09/2011 - 01/2004
3TamoxifenFDA LinkGeneric
03/2010 - 08/2004
3Daunorubicin (Cerubidine)FDA LinkGeneric
02/2010 - 01/2002
2Minichromosome Maintenance ProteinsIBA
02/2016 - 12/2013
2Aldehyde DehydrogenaseIBA
01/2016 - 09/2013
2Type I Tumor Necrosis Factor ReceptorsIBA
12/2015 - 01/2013
2Subfamily B ATP Binding Cassette TransporterIBA
08/2015 - 08/2013
2Extracellular Matrix ProteinsIBA
11/2014 - 01/2014
2EnzymesIBA
09/2013 - 12/2012
2Estrogens (Estrogen)FDA Link
09/2011 - 04/2011
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2011 - 07/2007
2Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
04/2006 - 01/2005
2nucleolar organizer region associated proteinsIBA
08/2004 - 01/2004
2Calcitonin (Calcitonin, Eel)FDA LinkGeneric
02/2004 - 11/2003
1Nuclear Proteins (Protein, Nuclear)IBA
06/2022
1Interferon-gamma (Interferon, gamma)IBA
06/2022
1Prostate-Specific Antigen (Semenogelase)IBA
09/2021
1Circulating Tumor DNAIBA
09/2021
1piperineIBA
04/2021
1Class 2 Receptor-Like Protein Tyrosine PhosphatasesIBA
04/2019
1Phosphoprotein Phosphatases (Phosphatases, Protein)IBA
04/2019
1Dichlorodiphenyl Dichloroethylene (DDE)IBA
01/2018
1Pyruvate KinaseIBA
01/2018
1LumicanIBA
09/2017

Therapy/Procedure

27Drug Therapy (Chemotherapy)
06/2022 - 09/2002
16Therapeutics
09/2021 - 01/2002
3Laparotomy
07/2012 - 09/2005
2Aftercare (After-Treatment)
04/2019 - 09/2011
1Precision Medicine
09/2021
1Immunotherapy
09/2021
1Coronary Artery Bypass (Coronary Artery Bypass Surgery)
10/2019
1Radiotherapy
06/2019